These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 32436467

  • 1. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z, Wegener D, Berger B, Zips D, Paulsen F, Bleif M, Thorwarth D, Alber M, Dohm O, Müller AC.
    Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of probabilistic dose-escalated IMRT in prostate cancer.
    Wegener D, Berger B, Outtagarts Z, Zips D, Paulsen F, Bleif M, Thorwarth D, Alber M, Dohm O, Müller AC.
    Radiol Oncol; 2020 Dec 22; 55(1):88-96. PubMed ID: 33885246
    [Abstract] [Full Text] [Related]

  • 3. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q, Liang J, Zhou D, Krauss DJ, Chen PY, Yan D.
    Int J Radiat Oncol Biol Phys; 2018 Jul 15; 101(4):985-997. PubMed ID: 29976511
    [Abstract] [Full Text] [Related]

  • 4. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W, Frank SJ, Li X, Li Y, Zhu RX, Mohan R.
    Med Phys; 2013 Feb 15; 40(2):021709. PubMed ID: 23387732
    [Abstract] [Full Text] [Related]

  • 5. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ, Johnson C, Turnbull D, Kempe J, Bzdusek K, Van Dyk J, Bauman G.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):874-80. PubMed ID: 23978708
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
    Chang Y, Xiao F, Quan H, Yang Z.
    Radiat Oncol; 2020 Oct 17; 15(1):241. PubMed ID: 33069253
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S, Croke J, Roustan-Delatour N, Belanger E, Avruch L, Malone C, Morash C, Kayser C, Underhill K, Li Y, Malone K, Nyiri B, Spaans J.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):725-32. PubMed ID: 22444999
    [Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, Wu QJ.
    Med Phys; 2012 Nov 01; 39(11):6868-78. PubMed ID: 23127079
    [Abstract] [Full Text] [Related]

  • 10. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1897-902. PubMed ID: 21536391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-shaping using targeted sparse optimization.
    Sayre GA, Ruan D.
    Med Phys; 2013 Jul 01; 40(7):071711. PubMed ID: 23822415
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
    Onal C, Efe E, Bozca R, Yavas C, Yavas G, Arslan G.
    J Appl Clin Med Phys; 2024 Jan 01; 25(1):e14179. PubMed ID: 38013636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Robust optimization in lung treatment plans accounting for geometric uncertainty.
    Zhang X, Rong Y, Morrill S, Fang J, Narayanasamy G, Galhardo E, Maraboyina S, Croft C, Xia F, Penagaricano J.
    J Appl Clin Med Phys; 2018 May 01; 19(3):19-26. PubMed ID: 29524301
    [Abstract] [Full Text] [Related]

  • 17. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
    Nguyen TTT, Arimura H, Asamura R, Hirose TA, Ohga S, Fukunaga JI.
    Radiol Phys Technol; 2019 Jun 01; 12(2):137-148. PubMed ID: 30805779
    [Abstract] [Full Text] [Related]

  • 18. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
    Murray LJ, Lilley J, Thompson CM, Cosgrove V, Mason J, Sykes J, Franks K, Sebag-Montefiore D, Henry AM.
    Int J Radiat Oncol Biol Phys; 2014 Jun 01; 89(2):406-15. PubMed ID: 24685447
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
    Yoo S, Wu QJ, Lee WR, Yin FF.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):935-42. PubMed ID: 20044214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.